My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    New federal initiatives to enhance the medical treatment of opioid dependence.

    Fiellin DA, O'Connor PG.

    Ann Intern Med. 2002 Oct 15;137(8):688-92.PMID: 12379070 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).

    [No authors listed]

    J Addict Dis. 2005;24(3):153-61. No abstract available. PMID: 16186090 [PubMed - indexed for MEDLINE]Related articles

    3.

    Consensus statement on office-based treatment of opioid dependence using buprenorphine.

    Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.

    J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.PMID: 15450648 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treating opioid dependence. Growing implications for primary care.

    Krantz MJ, Mehler PS.

    Arch Intern Med. 2004 Feb 9;164(3):277-88. Review.PMID: 14769623 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Provider satisfaction with office-based treatment of opioid dependence: a systematic review.

    Becker WC, Fiellin DA.

    Subst Abus. 2005 Mar;26(1):15-22. Review.PMID: 16492659 [PubMed - indexed for MEDLINE]Related articles

    6.

    American Society of Clinical Oncology policy statement: oversight of clinical research.

    American Society of Clinical Oncology.

    J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.PMID: 12721281 [PubMed - indexed for MEDLINE]Related articles

    7.

    The medical management of opioid dependence in HIV primary care settings.

    Lum PJ, Tulsky JP.

    Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. Review.PMID: 17089480 [PubMed - indexed for MEDLINE]Related articles

    8.

    Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence.

    Wong JG, Holmboe ES, Jara GB, Martin J, Becker WC, Fiellin DA.

    Subst Abus. 2004 Dec;25(4):35-40.PMID: 16172091 [PubMed - indexed for MEDLINE]Related articles

    9.

    Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.

    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services.

    Fed Regist. 2003 May 22;68(99):27937-9.PMID: 12762334 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Guideline development for office-based pharmacotherapies for opioid dependence.

    Fiellin DA, Barthwell AG; Center for Substance Abuse Treatment.

    J Addict Dis. 2003;22(4):109-20.PMID: 14723481 [PubMed - indexed for MEDLINE]Related articles

    11.

    Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.

    Turner BJ, Laine C, Lin YT, Lynch K.

    Arch Intern Med. 2005 Aug 8-22;165(15):1769-76.PMID: 16087826 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Managing opioid addiction with buprenorphine.

    Donaher PA, Welsh C.

    Am Fam Physician. 2006 May 1;73(9):1573-8. Review.PMID: 16719249 [PubMed - indexed for MEDLINE]Related articles

    13.

    Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.

    Drug Enforcement Administration (DEA), Justice.

    Fed Regist. 2005 Jun 23;70(120):36338-44.PMID: 15973789 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Office-based buprenorphine treatment for opioid-dependent patients.

    McCance-Katz EF.

    Harv Rev Psychiatry. 2004 Nov-Dec;12(6):321-38. Review.PMID: 15764468 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recent developments in health law.

    Weiner JL.

    J Law Med Ethics. 1996 Summer;24(2):158-62. No abstract available. PMID: 8945192 [PubMed - indexed for MEDLINE]Related articles

    16.

    Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

    Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

    Am J Addict. 2004;13 Suppl 1:S42-66.PMID: 15204675 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Innovations in agonist maintenance treatment of opioid-dependent patients.

    Haasen C, van den Brink W.

    Curr Opin Psychiatry. 2006 Nov;19(6):631-6. Review.PMID: 17012944 [PubMed - indexed for MEDLINE]Related articles

    18.

    Buprenorphine for office-based treatment of patients with opioid addiction.

    Manlandro JJ Jr.

    J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13. Review.PMID: 16118361 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Narrative review: buprenorphine for opioid-dependent patients in office practice.

    Sullivan LE, Fiellin DA.

    Ann Intern Med. 2008 May 6;148(9):662-70. Review.PMID: 18458279 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease.

    Gilson AM, Joranson DE.

    Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S91-8.PMID: 12479259 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity